US Lawmakers Want Answers From FDA On Infant Formula Shortage Following Abbott Recall

House Appropriations and Energy and Commerce subcommittees will ask about Abbott Nutrition’s recall of infant formula made at its Sturgis, MI, facility. “We are doing everything in our power to ensure there is adequate product available where and when they need it,” says FDA Commissioner Robert Califf.

• Source: Shutterstock

US lawmakers are demanding answers from the Food and Drug Administration about a shortage of infant formula products as demand for production by other firms grows following the closing of an Abbott Nutrition plant due to contamination concerns.

House Appropriations and Energy and Commerce subcommittee members also will ask about the recall by the Abbott Laboratories Ltd

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation